INIS
patients
100%
bladder
89%
urinary tract
50%
symptoms
48%
reviews
27%
females
24%
surgery
24%
cancer
22%
prostate
21%
therapy
20%
stimulation
19%
women
17%
men
17%
males
16%
management
16%
comparative evaluations
15%
nerves
15%
muscles
14%
quality of life
14%
data
13%
floors
13%
pain
12%
diseases
11%
values
10%
assessments
9%
risks
9%
devices
9%
adults
8%
control
8%
retention
8%
safety
8%
carcinomas
8%
evaluation
8%
guidelines
7%
interventions
7%
populations
7%
toxins
6%
storage
6%
interstitials
6%
hospitals
6%
recommendations
6%
implants
6%
radiotherapy
6%
volume
5%
injection
5%
balloons
5%
levels
5%
voids
5%
children
5%
urethra
5%
humans
5%
Medicine and Dentistry
Bladder
37%
Lower Urinary Tract Symptom
32%
Overactive Bladder
31%
Sacral Nerve Stimulation
24%
Stress Incontinence
17%
Incontinence
15%
Neuromodulation
14%
Quality of Life
13%
Detrusor
13%
Urodynamics
12%
Urination
11%
Systematic Review
10%
Disease
9%
Urinary Tract
9%
Prostate Cancer
9%
Pelvic Floor
9%
Pelvis
9%
Urine Incontinence
8%
Enuresis
8%
Continence
8%
Diagnosis
7%
Nocturia
7%
Urinary Retention
7%
Prevalence
6%
Interstitial Cystitis
6%
Adverse Event
6%
Cystalgia
6%
Consultation
6%
Implant
5%
Pain
5%
Neurostimulation
5%
Bladder Outlet Obstruction
5%
Sensation
5%
Urinary System
5%
Botulinum Toxin A
5%
Keyphrases
Overactive Bladder Symptom Score (OABSS)
40%
Lower Urinary Tract Symptoms
35%
Sacral Neuromodulation
26%
Bladder
19%
Incontinence
13%
Quality of Life
10%
Bladder Pain Syndrome
9%
Stress Urinary Incontinence
9%
Urinary Incontinence
9%
Neuromodulation
9%
Nocturia
9%
Detrusor Underactivity
8%
ICI-RS
8%
Lower Urinary Tract
7%
Urodynamics
7%
Female Stress Urinary Incontinence
7%
Urodynamic Study
6%
Interstitial Cystitis
6%
Botulinum Neurotoxin (BoNT)
6%
Adverse Events
5%
Ventrolateral Periaqueductal Gray (vlPAG)
5%
International Continence Society
5%
International Consultation
5%
Urinary Bladder
5%
Netherlands
5%
Pelvic Health
5%